NORVASC Market Exclusivity Period (MEP). When do the patents on NORVASC expire, and when will NORVASC go generic?
When do Norvasc patents expire, and when can generic versions of Norvasc launch?
Norvasc is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in NORVASC is amlodipine besylate. There are fifty drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the amlodipine besylate profile page.